Brolucizumab User Reviews & Ratings
Brand names: Beovu
Brolucizumab has an average rating of 7.0 out of 10 from a total of 3 reviews on drugclasses.com. 67% of reviewers reported a positive experience, while 33% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Macular Degeneration | 3 reviews for Macular Degeneration | 16 medications | |
Add your review |
- RMOK
- Taken for 10 years or more
- March 16, 2023
Beovu (brolucizumab) for Macular Degeneration "Have taken Wet AMD injections since 2011. Avastin for 6 months, Eyela for 7 1/2 years. Beovu 3 years and 3 months"
- jerry
- Taken for less than 1 month
- July 29, 2022
Beovu (brolucizumab) for Macular Degeneration "Stay away from Beovu - it blinded me in my left eye - use something else instead"
Frequently asked questions
- Does Beovu help with wet AMD?
- What is brolucizumab used for and how does it work?
- How is brolucizumab administered?
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about brolucizumab
- Compare alternatives
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Beovu (brolucizumab) for Macular Degeneration "Has been working much better than Eylea or lucentis and so much better not have to be injected every 30 days."